Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria

Human Molecular Genetics

Volumn 20, Issue 6, 2011, Pages 1197-1211

  Schmidt, Saskia ^a   Linnartz, Bettina ^a   Mendritzki, Sonja ^a   Sczepan, Teresa ^a   Lübbert, Matthias ^a   Stichel, Christine C ^c   Lübbert, Hermann ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Biofrontera Pharmaceuticals GmbH   (Germany)

^c SGO   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM ION; GLIAL FIBRILLARY ACIDIC PROTEIN; MITOCHONDRIAL PROTEIN; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN MITOCHONDRION; CELL DAMAGE; CELL STRUCTURE; CELL TYPE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; DISEASE SEVERITY; GENE DELETION; GENE MUTATION; GENETIC MODEL; GLIA CELL; IMMUNOREACTIVITY; MESENCEPHALON; MOUSE; NERVE CELL; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE;

ANIMALS; ASTROCYTES; CALCIUM; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; NEUROGLIA; NEURONS; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES;

MUS; MUS MUSCULUS;

EID: 79952020818     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq564     Document Type: Article

References (52)

1. Biskup, S., Gerlach, M., Kupsch, A., Reichmann, H., Riederer, P., Vieregge, P., Wullner, U. and Gasser, T. (2008) Genes associated with Parkinson syndrome. J Neurol., 255(Suppl. 5), 8-17.
2. Schiesling, C., Kieper, N., Seidel, K. and Kruger, R. (2008) Review: familial Parkinson's disease-genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol. Appl. Neurobiol., 34, 255-271.
3. Abou-Sleiman, P.M., Muqit, M.M. and Wood, N.W. (2006) Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci., 7, 207-219.
4. Schapira, A.H. (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol., 7, 97-109.
5. Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T. and Kagawa, Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun., 163, 1450-1455.
6. Schapira, A.H.V., Cooper, J.M., Dexter, D., Jenner, P., Clark, J.B. and Marsden, C.D. (1989) Mitochondrial complex I deficiency in parkinsons-disease. Lancet, 1, 1269.
7. Song, D.D., Shults, C.W., Sisk, A., Rockenstein, E. and Masliah, E. (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol., 186, 158-172.
8. Richfield, E.K., Thiruchelvam, M.J., Cory-Slechta, D.A., Wuertzer, C., Gainetdinov, R.R., Caron, M.G., Di Monte, D.A. and Federoff, H.J. (2002) Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp. Neurol., 175, 35-48.
9. Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. and Shen, J. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem., 279, 18614-18622.
10. Stichel, C.C., Zhu, X.R., Bader, V., Linnartz, B., Schmidt, S. and Lubbert, H. (2007) Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum. Mol. Genet., 16, 2377-2393.
11. Periquet, M., Corti, O., Jacquier, S. and Brice, A. (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J. Neurochem., 95, 1259-1276.
12. Poon, H.F., Frasier, M., Shreve, N., Calabrese, V., Wolozin, B. and Butterfield, D.A. (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice-a model of familial Parkinson's disease. Neurobiol. Dis., 18, 492-498.
13. Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H. and Wakabayashi, K. (2002) Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp. Neurol., 176, 98-104.
14. Austin, S.A., Floden, A.M., Murphy, E.J. and Combs, C.K. (2006) Alpha-synuclein expression modulates microglial activation phenotype. J. Neurosci., 26, 10558-10563.
15. Solano, R.M., Casarejos, M.J., Menendez-Cuervo, J., Rodriguez-Navarro, J.A., Garcia, d.Y. and Mena, M.A. (2008) Glial dysfunction in parkin null mice: effects of aging. J. Neurosci., 28, 598-611.
16. Mullett, S.J. and Hinkle, D.A. (2009) DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone. Neurobiol. Dis., 33, 28-36.
17. Martin, L.J., Pan, Y., Price, A.C., Sterling, W., Copeland, N.G., Jenkins, N.A., Price, D.L. and Lee, M.K. (2006) Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci., 26, 41-50.
18. Stichel, C.C., Augustin, M., Kuhn, K., Zhu, X.R., Engels, P., Ullmer, C. and Lubbert, H. (2000) Parkin expression in the adult mouse brain. Eur. J. Neurosci., 12, 4181-4194.
19. Huang, Y., Song, Y.J., Murphy, K., Holton, J.L., Lashley, T., Revesz, T., Gai, W.P. and Halliday, G.M. (2008) LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions. Acta Neuropathol., 116, 639-646.
20. Croisier, E. and Graeber, M.B. (2006) Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol., 112, 517-530.
21. Lobsiger, C.S. and Cleveland, D.W. (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci., 10, 1355-1360.
22. Kuroda, Y., Mitsui, T., Kunishige, M., Shono, M., Akaike, M., Azuma, H. and Matsumoto, T. (2006) Parkin enhances mitochondrial biogenesis in proliferating cells. Hum. Mol. Genet., 15, 883-895.
23. Maskri, L., Zhu, X., Fritzen, S., Kuhn, K., Ullmer, C., Engels, P., Andriske, M., Stichel, C.C. and Lubbert, H. (2004) Influence of different promoters on the expression pattern of mutated human alpha-synuclein in transgenic mice. Neurodegener. Dis., 1, 255-265.
24. Jouaville, L.S., Ichas, F. and Mazat, J.P. (1998) Modulation of cell calcium signals by mitochondria. Mol. Cell. Biochem., 184, 371-376.
25. Hayashida, K., Oyanagi, S., Mizutani, Y. and Yokochi, M. (1993) An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism. Acta Neuropathol. (Berl.), 85, 445-448.
26. Keeney, P.M., Xie, J., Capaldi, R.A. and Bennett, J.P. Jr (2006) Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci., 26, 5256-5264.
27. Henchcliffe, C. and Beal, M.F. (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol., 4, 600-609.
28. Terman, A., Gustafsson, B. and Brunk, U.T. (2007) Autophagy, organelles and ageing. J. Pathol., 211, 134-143.
29. Elmore, S.P., Qian, T., Grissom, S.F. and Lemasters, J.J. (2001) The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J., 15, 2286-2287.
30. Geisler, S., Holmstrom, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J. and Springer, W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol., 12, 119-131.
31. Deng, H., Dodson, M.W., Huang, H. and Guo, M. (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl Acad. Sci. USA, 105, 14503-14508.
32. Sung, J.Y., Park, S.M., Lee, C.H., Um, J.W., Lee, H.J., Kim, J., Oh, Y.J., Lee, S.T., Paik, S.R. and Chung, K.C. (2005) Proteolytic cleavage of extracellular secreted alpha-synuclein via matrix metalloproteinases. J. Biol. Chem., 280, 25216-25224.
33. Fortin, D.L., Nemani, V.M., Voglmaier, S.M., Anthony, M.D., Ryan, T.A. and Edwards, R.H. (2005) Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci., 25, 10913-10921.
34. Lee, S.J. (2008) Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease. J. Mol. Neurosci., 34, 17-22.
35. Zhang, W., Wang, T., Pei, Z., Miller, D.S., Wu, X., Block, M.L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.S. et al. (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J., 19, 533-542.
36. Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopherson, K.S., Xing, Y., Lubischer, J.L., Krieg, P.A., Krupenko, S.A. et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci., 28, 264-278.
37. Chew, S.H. (2004) Phagocytosis of degenerating myelin in transected feline optic nerve: an immunohistochemical study. Biotech. Histochem., 79, 177-183.
38. Lo, B.C., Ridet, J.L., Schneider, B.L., Deglon, N. and Aebischer, P. (2002) alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl Acad. Sci. USA, 99, 10813-10818.
39. Szabadkai, G. and Duchen, M.R. (2008) Mitochondria: the hub of cellular Ca2+ signaling. Physiology (Bethesda), 23, 84-94.
40. Furukawa, K., Matsuzaki-Kobayashi, M., Hasegawa, T., Kikuchi, A., Sugeno, N., Itoyama, Y., Wang, Y., Yao, P.J., Bushlin, I. and Takeda, A. (2006) Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J. Neurochem., 97, 1071-1077.
41. Marongiu, R., Spencer, B., Crews, L., Adame, A., Patrick, C., Trejo, M., Dallapiccola, B., Valente, E.M. and Masliah, E. (2009) Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J. Neurochem., 108, 1561-1574.
42. Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A. and Guo, M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 441, 1162-1166.
43. Poole, A.C., Thomas, R.E., Andrews, L.A., McBride, H.M., Whitworth, A.J. and Pallanck, L.J. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl Acad. Sci. USA, 105, 1638-1643.
44. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
45. Mena, M.A., de Bernardo, S., Casarejos, M.J., Canals, S. and Rodriguez-Martin, E. (2002) The role of astroglia on the survival of dopamine neurons. Mol. Neurobiol., 25, 245-263.
46. Meyer, M., Matarredona, E.R., Seiler, R.W., Zimmer, J. and Widmer, H.R. (2001) Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures. Neuroscience, 108, 273-284.
47. Pozas, E. and Ibanez, C.F. (2005) GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons. Neuron, 45, 701-713.
48. Ohgoh, M., Kimura, M., Ogura, H., Katayama, K. and Nishizawa, Y. (1998) Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support. Exp. Neurol., 149, 51-63.
49. Zhu, X.R., Maskri, L., Herold, C., Bader, V., Stichel, C.C., Gunturkun, O. and Lubbert, H. (2007) Non-motor behavioural impairments in parkin-deficient mice. Eur. J. Neurosci., 26, 1902-1911.
50. Stichel, C.C., Singer, W. and Zilles, K. (1990) Ultrastructure of PkC(II/ III)-immunopositive structures in rat primary visual cortex. Exp. Brain Res., 82, 575-584.
51. Liu, H.M. and Bahu, R.M. (1975) Ultrastructure of the nervous system. Ann. Clin. Lab Sci., 5, 348-354.
52. Peters, A., Palay, S.L. and Webster, H.D. (1976) The Fine Structure of the Nervous System, Saunders Company, Philadelphia.